| molecular function |
|---|
| | GO:0015485 | | cholesterol binding | | Interacting selectively and non-covalently with cholesterol (cholest-5-en-3-beta-ol); the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. |
| | GO:0008289 | | lipid binding | | Interacting selectively and non-covalently with a lipid. |
| | GO:0005319 | | lipid transporter activity | | Enables the directed movement of lipids into, out of or within a cell, or between cells. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0036094 | | small molecule binding | | Interacting selectively and non-covalently with a small molecule, any low molecular weight, monomeric, non-encoded molecule. |
| | GO:0005215 | | transporter activity | | Enables the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells. |
| biological process |
|---|
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:0001525 | | angiogenesis | | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| | GO:0007420 | | brain development | | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
| | GO:0006006 | | glucose metabolic process | | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
| | GO:0006629 | | lipid metabolic process | | The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids. |
| | GO:0006869 | | lipid transport | | The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
| | GO:2000405 | | negative regulation of T cell migration | | Any process that stops, prevents or reduces the frequency, rate or extent of T cell migration. |
| | GO:1900016 | | negative regulation of cytokine production involved in inflammatory response | | Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response. |
| | GO:0051895 | | negative regulation of focal adhesion assembly | | Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions. |
| | GO:0060588 | | negative regulation of lipoprotein lipid oxidation | | Any process that decreases the rate, frequency or extent of lipoprotein lipid oxidation. Lipoprotein lipid oxidation is the modification of a lipoprotein by oxidation of the lipid group. |
| | GO:0071638 | | negative regulation of monocyte chemotactic protein-1 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1. |
| | GO:0010642 | | negative regulation of platelet-derived growth factor receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway. |
| | GO:0042308 | | negative regulation of protein import into nucleus | | Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of proteins from the cytoplasm into the nucleus. |
| | GO:0048662 | | negative regulation of smooth muscle cell proliferation | | Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation. |
| | GO:2000098 | | negative regulation of smooth muscle cell-matrix adhesion | | Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell-matrix adhesion. |
| | GO:0014012 | | peripheral nervous system axon regeneration | | The regrowth of axons outside the central nervous system (outside the brain and spinal cord) following an axonal injury. |
| | GO:0048678 | | response to axon injury | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0000302 | | response to reactive oxygen species | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
| | GO:0042246 | | tissue regeneration | | The regrowth of lost or destroyed tissues. |
| | GO:0006810 | | transport | | The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein. |
| cellular component |
|---|
| | GO:0022626 | | cytosolic ribosome | | A ribosome located in the cytosol. |
| | GO:0030425 | | dendrite | | A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| | GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| | GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
Description
